{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:09:44Z","timestamp":1778904584169,"version":"3.51.4"},"reference-count":141,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.idc.2022.07.007","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T19:45:09Z","timestamp":1667245509000},"page":"861-887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["ICU Management of Invasive \u03b2-Hemolytic Streptococcal Infections"],"prefix":"10.1016","volume":"36","author":[{"given":"Ahmed","family":"Babiker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer S.","family":"Kadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.idc.2022.07.007_bib1","unstructured":"Procop GW, Church DL, Hall GS, et al. Gram-Positive Cocci Part II: Streptococci, Enterococci, and the \u201cStreptococcus-Like\u201d Bacteria. Koneman\u2019s Color Atlas and Textbook of Diagnostic Microbiology. Seventh ed: Wolters Kluwer."},{"issue":"4","key":"10.1016\/j.idc.2022.07.007_bib2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1128\/CMR.15.4.613-630.2002","article-title":"What happened to the streptococci: overview of taxonomic and nomenclature changes","volume":"15","author":"Facklam","year":"2002","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.idc.2022.07.007_bib3","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1084\/jem.57.4.571","article-title":"A SEROLOGICAL DIFFERENTIATION OF HUMAN AND OTHER GROUPS OF HEMOLYTIC STREPTOCOCCI","volume":"57","author":"Lancefield","year":"1933","journal-title":"J Exp Med"},{"key":"10.1016\/j.idc.2022.07.007_bib4","series-title":"The use of blood agar for the study of streptococci","author":"Brown","year":"1919"},{"issue":"12","key":"10.1016\/j.idc.2022.07.007_bib5","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1086\/648499","article-title":"The Naming of Strep, with Apologies to T. S. Eliot","volume":"49","author":"Musher","year":"2009","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.idc.2022.07.007_bib6","series-title":"Mandell, Douglas, and Bennett\u2019s Principle and Practice of Infectious Diseases","article-title":"Streptococcus agalactiae","author":"Edwards","year":"2020"},{"issue":"6","key":"10.1016\/j.idc.2022.07.007_bib7","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1086\/597035","article-title":"Population-Based Study of Invasive Disease Due to \u03b2-Hemolytic Streptococci of Groups Other than A and B","volume":"48","author":"Broyles","year":"2009","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.idc.2022.07.007_bib8","article-title":"Effectiveness of adjunctive clindamycin in \u03b2-lactam antibiotic-treated patients with invasive \u03b2-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study","author":"Babiker","year":"2020","journal-title":"The Lancet Infectious diseases"},{"issue":"1","key":"10.1016\/j.idc.2022.07.007_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1128\/CMR.1.1.102","article-title":"Streptococcus anginosus (\"Streptococcus milleri\"): the unrecognized pathogen","volume":"1","author":"Ruoff","year":"1988","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.idc.2022.07.007_bib10","series-title":"Principles and Practice of Infectious Diseases","article-title":"Classification of Streptocci","author":"Decker","year":"2020"},{"issue":"2","key":"10.1016\/j.idc.2022.07.007_bib11","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.00101-13","article-title":"Disease manifestations and pathogenic mechanisms of Group A Streptococcus","volume":"27","author":"Walker","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.idc.2022.07.007_bib12","series-title":"Mandell, Douglas, and Bennett\u2019s Principle and Practice of Infectious Diseases","article-title":"Streptococcus pyogenes","author":"Bryant","year":"2020"},{"issue":"1","key":"10.1016\/j.idc.2022.07.007_bib13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1128\/CMR.18.1.102-127.2005","article-title":"Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens","volume":"18","author":"Lindahl","year":"2005","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.idc.2022.07.007_bib14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1574-695X.1998.tb01162.x","article-title":"Identification of two genes, cpsX and cpsY, with putative regulatory function on capsule expression in group B streptococci","volume":"21","author":"Koskiniemi","year":"1998","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"5","key":"10.1016\/j.idc.2022.07.007_bib15","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1086\/605085","article-title":"Human infections due to Streptococcus dysgalactiae subspecies equisimilis","volume":"49","author":"Brandt","year":"2009","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"issue":"11","key":"10.1016\/j.idc.2022.07.007_bib16","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1086\/516780","article-title":"Virulence Profiling of Streptococcus dysgalactiae Subspecies equisimilis Isolated from Infected Humans Reveals 2 Distinct Genetic Lineages That Do Not Segregate with Their Phenotypes or Propensity to Cause Diseases","volume":"44","author":"Davies","year":"2007","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1016\/j.idc.2022.07.007_bib17","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1128\/JCM.42.1.186-192.2004","article-title":"Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome","volume":"42","author":"Hashikawa","year":"2004","journal-title":"Journal of clinical microbiology"},{"issue":"7","key":"10.1016\/j.idc.2022.07.007_bib18","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3201\/eid2307.161259","article-title":"Clonal Clusters and Virulence Factors of Group C and G Streptococcus Causing Severe Infections, Manitoba, Canada, 2012-2014","volume":"23","author":"Lother","year":"2017","journal-title":"Emerging infectious diseases"},{"issue":"7","key":"10.1016\/j.idc.2022.07.007_bib19","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1469-0691.2005.01169.x","article-title":"Invasive group A, B, C and G streptococcal infections in Denmark 1999\u20132002: epidemiological and clinical aspects","volume":"11","author":"Ekelund","year":"2005","journal-title":"Clinical Microbiology and Infection"},{"issue":"3","key":"10.1016\/j.idc.2022.07.007_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0020-2018","article-title":"Pathogenicity Factors in Group C and G Streptococci","volume":"7","author":"Turner","year":"2019","journal-title":"Microbiol Spectr"},{"issue":"1","key":"10.1016\/j.idc.2022.07.007_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/bmb\/ldv027","article-title":"Invasive streptococcal disease: a review for clinicians","volume":"115","author":"Parks","year":"2015","journal-title":"Br Med Bull"},{"key":"10.1016\/j.idc.2022.07.007_bib22","unstructured":"Centers for Disease Control and Prevention. Group A Streptococcal (GAS) Disease. 2018. https:\/\/www.cdc.gov\/groupastrep\/surveillance.html (accessed Feb 7th 2022)."},{"issue":"5","key":"10.1016\/j.idc.2022.07.007_bib23","first-page":"1400","article-title":"Necrotizing soft tissue infections: delayed surgical treatment is associated with increased number of surgical debridements and morbidity","volume":"71","author":"Kobayashi","year":"2011","journal-title":"J Trauma"},{"issue":"3","key":"10.1016\/j.idc.2022.07.007_bib24","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1469-0691.2008.02672.x","article-title":"Clinical presentations and epidemiology of beta-haemolytic streptococcal bacteraemia: a population-based study","volume":"15","author":"Rantala","year":"2009","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.idc.2022.07.007_bib25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3201\/eid1402.070888","article-title":"Severe Streptococcus pyogenes infections, United Kingdom, 2003-2004","volume":"14","author":"Lamagni","year":"2008","journal-title":"Emerging infectious diseases"},{"issue":"1","key":"10.1016\/j.idc.2022.07.007_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/clinids\/14.1.2","article-title":"Invasive group A streptococcus infections","volume":"14","author":"Stevens","year":"1992","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"issue":"9","key":"10.1016\/j.idc.2022.07.007_bib27","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2165\/11634180-000000000-00000","article-title":"Invasive group a streptococcal disease: epidemiology, pathogenesis and management","volume":"72","author":"Steer","year":"2012","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.idc.2022.07.007_bib28","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/cid\/cir726","article-title":"Invasive bacterial infections in relation to influenza outbreaks, 2006-2010","volume":"53","author":"Tasher","year":"2011","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"issue":"5","key":"10.1016\/j.idc.2022.07.007_bib29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(09)70066-0","article-title":"Gram-positive toxic shock syndromes","volume":"9","author":"Lappin","year":"2009","journal-title":"The Lancet Infectious Diseases"},{"issue":"9719","key":"10.1016\/j.idc.2022.07.007_bib30","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0140-6736(10)60052-9","article-title":"Nosocomial transmission of necrotising fasciitis","volume":"375","author":"Sablier","year":"2010","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.idc.2022.07.007_bib31","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/cid\/ciu752","article-title":"Global Assessment of Invasive Group A Streptococcus Infection Risk in Household Contacts","volume":"60","author":"Lamagni","year":"2014","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1016\/j.idc.2022.07.007_bib32","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/cid\/ciu304","article-title":"Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections","volume":"59","author":"Carapetis","year":"2014","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"issue":"7","key":"10.1016\/j.idc.2022.07.007_bib33","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/cid\/ciz716","article-title":"Evaluating Household Transmission of Invasive Group A Streptococcus Disease in the United States Using Population-based Surveillance Data","volume":"70","author":"Adebanjo","year":"2020","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"issue":"8","key":"10.1016\/j.idc.2022.07.007_bib34","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/342692","article-title":"Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers for Disease Control and Prevention","volume":"35","year":"2002","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"issue":"4","key":"10.1016\/j.idc.2022.07.007_bib35","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3201\/eid0904.020369","article-title":"Risk for severe group A streptococcal disease among patients' household contacts","volume":"9","author":"Robinson","year":"2003","journal-title":"Emerging infectious diseases"},{"issue":"5","key":"10.1016\/j.idc.2022.07.007_bib36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1086\/502567","article-title":"Molecular characterization of Streptococcus pyogenes isolates to investigate an outbreak of puerperal sepsis","volume":"26","author":"Raymond","year":"2005","journal-title":"Infection control and hospital epidemiology"},{"issue":"7","key":"10.1016\/j.idc.2022.07.007_bib37","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1128\/JCM.00679-13","article-title":"Molecular analysis of an outbreak of lethal postpartum sepsis caused by Streptococcus pyogenes","volume":"51","author":"Turner","year":"2013","journal-title":"Journal of clinical microbiology"},{"issue":"3","key":"10.1016\/j.idc.2022.07.007_bib38","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1086\/431589","article-title":"Hospital-Acquired Invasive Group A Streptococcal Infections in Ontario, Canada, 1992\u20132000","volume":"41","author":"Daneman","year":"2005","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.idc.2022.07.007_bib39","article-title":"Streptococcus pyogenes pbp2x Mutation Confers Reduced Susceptibility to \u03b2-lactam antibiotics","author":"Vannice","year":"2019","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.idc.2022.07.007_bib40","unstructured":"Centers for Disease Control and Prevention. Group B Strep (GBS) 2020. https:\/\/www.cdc.gov\/groupbstrep\/clinicians\/index.html (accessed Feb 7th 2022)."},{"issue":"4","key":"10.1016\/j.idc.2022.07.007_bib41","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jamainternmed.2018.7269","article-title":"Epidemiology of Invasive Group B Streptococcal Infections Among Nonpregnant Adults in the United States, 2008-2016","volume":"179","author":"Francois Watkins","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.idc.2022.07.007_bib42","unstructured":"Centers for Disease Control and Prevention. ABCs Bact Facts interactive data dashboard: group B Streptococcus (2019). 2021. https:\/\/www-cdc-gov\/abcs\/bact-facts-interactive-dashboard.html (accessed April 6th 2022)."},{"issue":"12","key":"10.1016\/j.idc.2022.07.007_bib43","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.18324","article-title":"Risk Factors and Mortality Rates Associated With Invasive Group B Streptococcus Infections Among Patients in the US Veterans Health Administration","volume":"2","author":"Jump","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.idc.2022.07.007_bib44","doi-asserted-by":"crossref","first-page":"415","DOI":"10.7326\/0003-4819-123-6-199509150-00003","article-title":"Risk factors for group B streptococcal disease in adults","volume":"123","author":"Jackson","year":"1995","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.idc.2022.07.007_bib45","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1469-0691.2010.03427.x","article-title":"Bacteraemia caused by beta-haemolytic streptococci in North Queensland: changing trends over a 14-year period","volume":"17","author":"Harris","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"10.1016\/j.idc.2022.07.007_bib46","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3201\/eid1008.030840","article-title":"Group G streptococcal bacteremia in Jerusalem","volume":"10","author":"Cohen-Poradosu","year":"2004","journal-title":"Emerging infectious diseases"},{"issue":"8","key":"10.1016\/j.idc.2022.07.007_bib47","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s10096-014-2092-0","article-title":"Streptococcus dysgalactiae subsp. equisimilis bacteremia: an emerging infection","volume":"33","author":"Rantala","year":"2014","journal-title":"European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology"},{"key":"10.1016\/j.idc.2022.07.007_bib48","series-title":"Mandell, Douglas, and Bennett\u2019s Principle and Practice of Infectious Diseases","article-title":"Viridans Streptococci, Nutrionally Variant Streptococci, and Group C and G Streptococci","author":"Cunha","year":"2020"},{"issue":"Rr-10","key":"10.1016\/j.idc.2022.07.007_bib49","first-page":"1","article-title":"Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention","volume":"46","year":"1997","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"10.1016\/j.idc.2022.07.007_bib50","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/cid\/ciw248","article-title":"Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005-2012","volume":"63","author":"Nelson","year":"2016","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"issue":"1","key":"10.1016\/j.idc.2022.07.007_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198907063210101","article-title":"Severe Group A Streptococcal Infections Associated with a Toxic Shock-like Syndrome and Scarlet Fever Toxin A","volume":"321","author":"Stevens","year":"1989","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.idc.2022.07.007_bib52","unstructured":"Centers for Disease Control and Prevention. Streptococcal Toxic Shock Syndrome. 2020. https:\/\/www.cdc.gov\/groupastrep\/diseases-hcp\/Streptococcal-Toxic-Shock-Syndrome.html (accessed April 6th 2022)"},{"issue":"10","key":"10.1016\/j.idc.2022.07.007_bib53","doi-asserted-by":"crossref","first-page":"e0206289","DOI":"10.1371\/journal.pone.0206289","article-title":"Secular trends in incidence of invasive beta-hemolytic streptococci and efficacy of adjunctive therapy in Quebec, Canada, 1996-2016","volume":"13","author":"Couture-Cossette","year":"2018","journal-title":"PloS one"},{"issue":"6","key":"10.1016\/j.idc.2022.07.007_bib54","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/cid\/ciu449","article-title":"Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study","volume":"59","author":"Linner","year":"2014","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"issue":"2","key":"10.1016\/j.idc.2022.07.007_bib55","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/cid\/ciu444","article-title":"Executive Summary: Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"10.1016\/j.idc.2022.07.007_bib56","first-page":"416","article-title":"Necrotizing fasciitis","volume":"18","author":"Wilson","year":"1952","journal-title":"Am Surg"},{"issue":"1","key":"10.1016\/j.idc.2022.07.007_bib57","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1086\/653116","article-title":"Getting under the skin: the immunopathogenesis of Streptococcus pyogenes deep tissue infections","volume":"51","author":"Johansson","year":"2010","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"issue":"3","key":"10.1016\/j.idc.2022.07.007_bib58","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.idc.2017.05.011","article-title":"Evaluation and Management of Necrotizing Soft Tissue Infections","volume":"31","author":"Bonne","year":"2017","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.idc.2022.07.007_bib59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijid.2015.04.021","article-title":"Red Flags for Necrotizing Fasciitis: A Case Control Study","volume":"36","author":"Alayed","year":"2015","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2022.07.007_bib60","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0002-9343(97)00160-5","article-title":"Population-based surveillance for group A streptococcal necrotizing fasciitis: Clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study","volume":"103","author":"Kaul","year":"1997","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.idc.2022.07.007_bib61","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/bjs.1800780431","article-title":"Necrotizing fasciitis: 10 years' experience in a district general hospital","volume":"78","author":"Ward","year":"1991","journal-title":"Br J Surg"},{"key":"10.1016\/j.idc.2022.07.007_bib62","unstructured":"Centers for Disease Control and Prevention. Group A Streptococcal (GAS) Surveillance Report. 2019. https:\/\/www.cdc.gov\/abcs\/downloads\/GAS_Surveillance_Report_2019.pdf (accessed Feb 7th 2022)."},{"issue":"3","key":"10.1016\/j.idc.2022.07.007_bib63","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3201\/eid0103.950301","article-title":"Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment","volume":"1","author":"Stevens","year":"1995","journal-title":"Emerging infectious diseases"},{"issue":"3","key":"10.1016\/j.idc.2022.07.007_bib64","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.1993.03500030088038","article-title":"Defining the Group A Streptococcal Toxic Shock Syndrome: Rationale and Consensus Definition","volume":"269","author":"Breiman","year":"1993","journal-title":"Jama"},{"issue":"Rr-10","key":"10.1016\/j.idc.2022.07.007_bib65","first-page":"1","article-title":"Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010","volume":"59","author":"Verani","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"10.1016\/j.idc.2022.07.007_bib66","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1469-0691.2010.03253.x","article-title":"Invasive group A, C and G streptococcal disease in western Norway: virulence gene profiles, clinical features and outcomes","volume":"17","author":"Kittang","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10.1016\/j.idc.2022.07.007_bib67","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1128\/JCM.39.9.3147-3155.2001","article-title":"Group G beta-hemolytic streptococcal bacteremia characterized by 16S ribosomal RNA gene sequencing","volume":"39","author":"Woo","year":"2001","journal-title":"Journal of clinical microbiology"},{"issue":"1","key":"10.1016\/j.idc.2022.07.007_bib68","doi-asserted-by":"crossref","first-page":"115207","DOI":"10.1016\/j.diagmicrobio.2020.115207","article-title":"Identification of Streptococcus dysgalactiae using matrix-assisted laser desorption\/ionization-time of flight mass spectrometry; refining the database for improved identification","volume":"99","author":"Nybakken","year":"2021","journal-title":"Diagnostic Microbiology and Infectious Disease"},{"issue":"9","key":"10.1016\/j.idc.2022.07.007_bib69","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1128\/JCM.00582-17","article-title":"Reliable Detection of Group B Streptococcus in the Clinical Laboratory","volume":"55","author":"Rosa-Fraile","year":"2017","journal-title":"Journal of clinical microbiology"},{"issue":"23","key":"10.1016\/j.idc.2022.07.007_bib70","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1056\/NEJMra1600673","article-title":"Necrotizing Soft-Tissue Infections","volume":"377","author":"Stevens","year":"2017","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.idc.2022.07.007_bib71","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1097\/01.CCM.0000129486.35458.7D","article-title":"The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections","volume":"32","author":"Wong","year":"2004","journal-title":"Critical care medicine"},{"key":"10.1016\/j.idc.2022.07.007_bib72","doi-asserted-by":"crossref","first-page":"42179","DOI":"10.1038\/srep42179","article-title":"Association between cytokine response, the LRINEC score and outcome in patients with necrotising soft tissue infection: a multicentre, prospective study","volume":"7","author":"Hansen","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.idc.2022.07.007_bib73","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13017-018-0219-9","article-title":"2018 WSES\/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections","volume":"13","author":"Sartelli","year":"2018","journal-title":"World Journal of Emergency Surgery"},{"issue":"1","key":"10.1016\/j.idc.2022.07.007_bib74","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00024-17","article-title":"Syndromic Panel-Based Testing in Clinical Microbiology","volume":"31","author":"Ramanan","year":"2017","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"10.1016\/j.idc.2022.07.007_bib75","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/cid\/ciw494","article-title":"Multiplexed Molecular Diagnostics for Respiratory, Gastrointestinal, and Central Nervous System Infections","volume":"63","author":"Hanson","year":"2016","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"issue":"3","key":"10.1016\/j.idc.2022.07.007_bib76","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive care medicine"},{"issue":"2","key":"10.1016\/j.idc.2022.07.007_bib77","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1473-3099(20)30477-1","article-title":"Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals","volume":"21","author":"Kadri","year":"2021","journal-title":"The Lancet Infectious diseases"},{"issue":"6","key":"10.1016\/j.idc.2022.07.007_bib78","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Critical care medicine"},{"issue":"1","key":"10.1016\/j.idc.2022.07.007_bib79","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13017-019-0286-6","article-title":"Time is of the essence when treating necrotizing soft tissue infections: a systematic review and meta-analysis","volume":"15","author":"Nawijn","year":"2020","journal-title":"World Journal of Emergency Surgery"},{"issue":"21","key":"10.1016\/j.idc.2022.07.007_bib80","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.idc.2022.07.007_bib81","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/viru.27372","article-title":"Epidemiology of severe sepsis","volume":"5","author":"Mayr","year":"2014","journal-title":"Virulence"},{"key":"10.1016\/j.idc.2022.07.007_bib82","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jgar.2020.04.032","article-title":"Emerging erythromycin and clindamycin resistance in group A streptococci: Efficacy of linezolid and tedizolid in experimental necrotizing infection","volume":"22","author":"Bryant","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.idc.2022.07.007_bib83","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3389\/fmicb.2020.00797","article-title":"Emerging Threat of Antimicrobial Resistance in \u03b2-Hemolytic Streptococci","volume":"11","author":"Oppegaard","year":"2020","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.idc.2022.07.007_bib84","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/0974-2700.173868","article-title":"Early surgical intervention and its impact on patients presenting with necrotizing soft tissue infections: A single academic center experience","volume":"9","author":"Hadeed","year":"2016","journal-title":"J Emerg Trauma Shock"},{"key":"10.1016\/j.idc.2022.07.007_bib85","doi-asserted-by":"crossref","unstructured":"V K, Hiremath BV, V A I. Necrotising soft tissue infection-risk factors for mortality. J Clin Diagn Res 2013; 7(8): 1662-1665.","DOI":"10.7860\/JCDR\/2013\/5535.3240"},{"issue":"5","key":"10.1016\/j.idc.2022.07.007_bib86","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00134-008-1373-4","article-title":"Influence of surgical treatment timing on mortality from necrotizing soft tissue infections requiring intensive care management","volume":"35","author":"Boyer","year":"2009","journal-title":"Intensive care medicine"},{"issue":"8","key":"10.1016\/j.idc.2022.07.007_bib87","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1067\/j.cpsurg.2014.06.001","article-title":"Necrotizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomes","volume":"51","author":"Hakkarainen","year":"2014","journal-title":"Curr Probl Surg"},{"issue":"10","key":"10.1016\/j.idc.2022.07.007_bib88","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1177\/000313481307901025","article-title":"Timing of Red\u00e9bridement after Initial Source Control Impacts Survival in Necrotizing Soft Tissue Infection","volume":"79","author":"Okoye","year":"2013","journal-title":"The American Surgeon"},{"issue":"2","key":"10.1016\/j.idc.2022.07.007_bib89","first-page":"269","article-title":"Clindamycin Affects Group A Streptococcus Virulence Factors and Improves Clinical Outcome","volume":"215","author":"Andreoni","year":"2017","journal-title":"The Journal of infectious diseases"},{"issue":"4","key":"10.1016\/j.idc.2022.07.007_bib90","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0002-9343(52)90293-3","article-title":"Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice","volume":"13","author":"Eagle","year":"1952","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.idc.2022.07.007_bib91","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/infdis\/158.1.23","article-title":"The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis","volume":"158","author":"Stevens","year":"1988","journal-title":"The Journal of infectious diseases"},{"issue":"12","key":"10.1016\/j.idc.2022.07.007_bib92","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/00006454-199912000-00014","article-title":"Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection","volume":"18","author":"Zimbelman","year":"1999","journal-title":"The Pediatric infectious disease journal"},{"issue":"10","key":"10.1016\/j.idc.2022.07.007_bib93","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/01.SMJ.0000051060.95210.9A","article-title":"Invasive group A streptococcal infections in Florida","volume":"96","author":"Mulla","year":"2003","journal-title":"Southern medical journal"},{"issue":"2","key":"10.1016\/j.idc.2022.07.007_bib94","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10096-021-04376-2","article-title":"Association between adjunct clindamycin and in-hospital mortality in patients with necrotizing soft tissue infection due to group A Streptococcus: a nationwide cohort study","volume":"41","author":"Hamada","year":"2022","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"issue":"2","key":"10.1016\/j.idc.2022.07.007_bib95","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/cid\/ciaa027","article-title":"Risk Factors and Predictors of Mortality in Streptococcal Necrotizing Soft-tissue Infections: A Multicenter Prospective Study","volume":"72","author":"Bruun","year":"2021","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"issue":"1","key":"10.1016\/j.idc.2022.07.007_bib96","doi-asserted-by":"crossref","first-page":"e634","DOI":"10.1002\/ams2.634","article-title":"In-hospital mortality among patients with invasive non-group A \u03b2-hemolytic Streptococcus treated with clindamycin combination therapy: a nationwide cohort study","volume":"8","author":"Hamada","year":"2021","journal-title":"Acute medicine & surgery"},{"issue":"1","key":"10.1016\/j.idc.2022.07.007_bib97","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1469-0691.2007.01881.x","article-title":"Prevalence and mechanisms of erythromycin and clindamycin resistance in clinical isolates of \u03b2-haemolytic streptococci of Lancefield groups A, B, C and G in Seville, Spain","volume":"14","author":"Merino D\u00edaz","year":"2008","journal-title":"Clinical Microbiology and Infection"},{"issue":"11","key":"10.1016\/j.idc.2022.07.007_bib98","doi-asserted-by":"crossref","first-page":"6928","DOI":"10.1128\/AAC.03855-14","article-title":"Molecular characterization of Streptococcus agalactiae isolates harboring small erm(T)-carrying plasmids","volume":"58","author":"Compain","year":"2014","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"2","key":"10.1016\/j.idc.2022.07.007_bib99","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.ARBA-0008-2017","article-title":"Antimicrobial Resistance in Streptococcus spp","volume":"6","author":"Haenni","year":"2018","journal-title":"Microbiol Spectr"},{"issue":"11","key":"10.1016\/j.idc.2022.07.007_bib100","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/cid\/ciab575","article-title":"Patterns of Antibiotic Nonsusceptibility Among Invasive Group A Streptococcus Infections\u2014United States, 2006\u20132017","volume":"73","author":"Fay","year":"2021","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.idc.2022.07.007_bib101","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jor.2020.03.015","article-title":"Beta-hemolytic group a streptococcal orthopaedic infections: Our institutional experience and review of the literature","volume":"21","author":"Nori","year":"2020","journal-title":"J Orthop"},{"issue":"5","key":"10.1016\/j.idc.2022.07.007_bib102","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1128\/AAC.47.5.1752-1755.2003","article-title":"Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin a release","volume":"47","author":"Coyle","year":"2003","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"10.1016\/j.idc.2022.07.007_bib103","article-title":"Successful Treatment of Necrotizing Fasciitis and Streptococcal Toxic Shock Syndrome with the Addition of Linezolid","volume":"2017","author":"Rac","year":"2017","journal-title":"Case Rep Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2022.07.007_bib104","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1128\/AAC.40.4.829","article-title":"Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of beta-lactam antibiotics","volume":"40","author":"Grebe","year":"1996","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"4","key":"10.1016\/j.idc.2022.07.007_bib105","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01993-19","article-title":"Reduced In Vitro Susceptibility of Streptococcus pyogenes to \u03b2-Lactam Antibiotics Associated with Mutations in the pbp2x Gene Is Geographically Widespread","volume":"58","author":"Musser","year":"2020","journal-title":"Journal of clinical microbiology"},{"issue":"12","key":"10.1016\/j.idc.2022.07.007_bib106","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1093\/jac\/dkw320","article-title":"Description and characterization of a penicillin-resistant Streptococcus dysgalactiae subsp. equisimilis clone isolated from blood in three epidemiologically linked patients","volume":"71","author":"Fuursted","year":"2016","journal-title":"The Journal of antimicrobial chemotherapy"},{"issue":"8","key":"10.1016\/j.idc.2022.07.007_bib107","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.cmi.2017.02.021","article-title":"Short-read whole genome sequencing for determination of antimicrobial resistance mechanisms and capsular serotypes of current invasive Streptococcus agalactiae recovered in the USA","volume":"23","author":"Metcalf","year":"2017","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.idc.2022.07.007_bib108","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ijantimicag.2010.02.010","article-title":"Prevalence and molecular mechanism of macrolide resistance in beta-haemolytic streptococci in The Netherlands","volume":"35","author":"Buter","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.idc.2022.07.007_bib109","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.2147\/IDR.S279157","article-title":"Beta-Haemolytic Group A, C and G Streptococcal Infections in Southern Hungary: A 10-Year Population-Based Retrospective Survey (2008-2017) and a Review of the Literature","volume":"13","author":"Gajd\u00e1cs","year":"2020","journal-title":"Infect Drug Resist"},{"issue":"1","key":"10.1016\/j.idc.2022.07.007_bib110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jac\/dkl173","article-title":"Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation","volume":"58","author":"Sriskandan","year":"2006","journal-title":"The Journal of antimicrobial chemotherapy"},{"issue":"9","key":"10.1016\/j.idc.2022.07.007_bib111","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/00365540310015944","article-title":"Intravenous Immunoglobulin Adjunctive Therapy in Sepsis, with Special Emphasis on Severe Invasive Group A Streptococcal Infections","volume":"35","author":"Norrby-teglund","year":"2003","journal-title":"Scandinavian Journal of Infectious Diseases"},{"issue":"6","key":"10.1016\/j.idc.2022.07.007_bib112","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0012-3692(15)50887-8","article-title":"Morbidity and mortality of patients with invasive group A streptococcal infections admitted to the ICU","volume":"130","author":"Mehta","year":"2006","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.idc.2022.07.007_bib113","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/cid\/ciy401","article-title":"Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis","volume":"67","author":"Parks","year":"2018","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"10.1016\/j.idc.2022.07.007_bib114","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/515199","article-title":"Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group","volume":"28","author":"Kaul","year":"1999","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"issue":"3","key":"10.1016\/j.idc.2022.07.007_bib115","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/376630","article-title":"Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial","volume":"37","author":"Darenberg","year":"2003","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"issue":"7","key":"10.1016\/j.idc.2022.07.007_bib116","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/cid\/ciw871","article-title":"Impact of Intravenous Immunoglobulin on Survival in Necrotizing Fasciitis With Vasopressor-Dependent Shock: A Propensity Score-Matched Analysis From 130 US Hospitals","volume":"64","author":"Kadri","year":"2017","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"issue":"11","key":"10.1016\/j.idc.2022.07.007_bib117","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00134-017-4786-0","article-title":"Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial","volume":"43","author":"Madsen","year":"2017","journal-title":"Intensive care medicine"},{"issue":"4","key":"10.1016\/j.idc.2022.07.007_bib118","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.amjsurg.2005.01.012","article-title":"Hyperbaric oxygen as adjuvant therapy in the management of necrotizing fasciitis","volume":"189","author":"Jallali","year":"2005","journal-title":"Am J Surg"},{"issue":"6","key":"10.1016\/j.idc.2022.07.007_bib119","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/jamasurg.2013.4841","article-title":"A Novel Drug for Treatment of Necrotizing Soft-Tissue Infections: A Randomized Clinical Trial","volume":"149","author":"Bulger","year":"2014","journal-title":"JAMA Surgery"},{"issue":"9","key":"10.1016\/j.idc.2022.07.007_bib120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001149","article-title":"Binding of superantigen toxins into the CD28 homodimer interface is essential for induction of cytokine genes that mediate lethal shock","volume":"9","author":"Arad","year":"2011","journal-title":"PLoS Biol"},{"issue":"12","key":"10.1016\/j.idc.2022.07.007_bib121","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/infdis\/jit104","article-title":"A peptide antagonist of CD28 signaling attenuates toxic shock and necrotizing soft-tissue infection induced by Streptococcus pyogenes","volume":"207","author":"Ramachandran","year":"2013","journal-title":"The Journal of infectious diseases"},{"issue":"4","key":"10.1016\/j.idc.2022.07.007_bib122","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/TA.0000000000001564","article-title":"Validation of a clinical trial composite endpoint for patients with necrotizing soft tissue infections","volume":"83","author":"Bulger","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"issue":"3","key":"10.1016\/j.idc.2022.07.007_bib123","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/SLA.0000000000004102","article-title":"A Novel Immune Modulator for Patients With Necrotizing Soft Tissue Infections (NSTI): Results of a Multicenter, Phase 3 Randomized Controlled Trial of Reltecimod (AB 103)","volume":"272","author":"Bulger","year":"2020","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.idc.2022.07.007_bib124","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/SLA.0000000000004135","article-title":"Commentary on \"Results of a Multicenter, Phase 3 Randomized Controlled Trial of Reltecimod","volume":"272","author":"Nathens","year":"2020","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.idc.2022.07.007_bib125","first-page":"354","article-title":"Interim UK guidelines for management of close community contacts of invasive group A streptococcal disease","volume":"7","year":"2004","journal-title":"Commun Dis Public Health"},{"issue":"5","key":"10.1016\/j.idc.2022.07.007_bib126","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/pch\/15.5.295","article-title":"Invasive group A streptococcal disease: Management and chemoprophylaxis","volume":"15","author":"Allen","year":"2010","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.idc.2022.07.007_bib127","series-title":"WHO recommendations for prevention and treatment of maternal peripartum infections","author":"World Health Organization","year":"2015"},{"issue":"4","key":"10.1016\/j.idc.2022.07.007_bib128","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ajog.2014.01.019","article-title":"Transplacental passage of vancomycin from mother to neonate","volume":"210","author":"Onwuchuruba","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.idc.2022.07.007_bib129","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/QCO.0000000000000644","article-title":"Update on group A streptococcal vaccine development","volume":"33","author":"Dale","year":"2020","journal-title":"Current opinion in infectious diseases"},{"issue":"6","key":"10.1016\/j.idc.2022.07.007_bib130","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41588-019-0417-8","article-title":"Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics","volume":"51","author":"Davies","year":"2019","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.idc.2022.07.007_bib131","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/cid\/ciy1143","article-title":"The Path to Group A Streptococcus Vaccines: World Health Organization Research and Development Technology Roadmap and Preferred Product Characteristics","volume":"69","author":"Vekemans","year":"2019","journal-title":"Clinical Infectious Diseases"},{"issue":"7","key":"10.1016\/j.idc.2022.07.007_bib132","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198658","article-title":"Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial","volume":"13","author":"Sekuloski","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.idc.2022.07.007_bib133","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.vaccine.2019.12.005","article-title":"Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I study","volume":"38","author":"Pastural","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.idc.2022.07.007_bib134","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ics.2005.12.002","article-title":"A double-blind, randomized phase II trial of the safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults","volume":"1289","author":"McNeil","year":"2006","journal-title":"International Congress Series"},{"issue":"50","key":"10.1016\/j.idc.2022.07.007_bib135","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.1016\/j.vaccine.2016.12.029","article-title":"WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27-28 April 2016","volume":"37","author":"Kobayashi","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.idc.2022.07.007_bib136","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2147\/IDR.S203454","article-title":"A Vaccine Against Group B Streptococcus: Recent Advances","volume":"13","author":"Carreras-Abad","year":"2020","journal-title":"Infect Drug Resist"},{"issue":"1","key":"10.1016\/j.idc.2022.07.007_bib137","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/infdis\/jiz062","article-title":"A Novel Hexavalent Capsular Polysaccharide Conjugate Vaccine (GBS6) for the Prevention of Neonatal Group B Streptococcal Infections by Maternal Immunization","volume":"220","author":"Buurman","year":"2019","journal-title":"The Journal of infectious diseases"},{"issue":"32","key":"10.1016\/j.idc.2022.07.007_bib138","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1016\/j.vaccine.2021.06.046","article-title":"Safety and immunogenicity of a prototype recombinant alpha-like protein subunit vaccine (GBS-NN) against Group B Streptococcus in a randomised placebo-controlled double-blind phase 1 trial in healthy adult women","volume":"39","author":"Fischer","year":"2021","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.idc.2022.07.007_bib139","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"The Lancet Infectious diseases"},{"issue":"2","key":"10.1016\/j.idc.2022.07.007_bib140","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00230-21","article-title":"mSphere of Influence: Whole-Genome Sequencing, a Vital Tool for the Interruption of Nosocomial Transmission","volume":"6","author":"Babiker","year":"2021","journal-title":"mSphere"},{"issue":"1","key":"10.1016\/j.idc.2022.07.007_bib141","doi-asserted-by":"crossref","first-page":"dlac014","DOI":"10.1093\/jacamr\/dlac014","article-title":"Clindamycin adjunctive therapy for severe Staphylococcus aureus treatment evaluation (CASSETTE)-an open-labelled pilot randomized controlled trial","volume":"4","author":"Campbell","year":"2022","journal-title":"JAC Antimicrob Resist"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552022000587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552022000587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:30:05Z","timestamp":1760196605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552022000587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":141,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0891552022000587"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2022.07.007","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ICU Management of Invasive \u03b2-Hemolytic Streptococcal Infections","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2022.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}